Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06329427 · ClinicalTrials.gov registry record · NA

Dragon Ambient eXperience (DAX) Copilot Evaluation

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
238
Enrollment target

NCT06329427: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT06329427 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 238 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06329427, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
238 participants
Enrollment target

Study Summary

AI solutions like, Dragon Ambient eXperience (DAX) Copilot (Nuance/Microsoft), hold the potential to significantly enhance provider and patient interactions and alleviate pain points that contribute to burn out. Atrium Health was the first healthcare system in the world to pilot Nuance's DAX Copilot intelligence (AI) enabled scribe software, which synthesizes a draft clinic note by "listening" to the conversation between a provider and patient. After 180 days of use by primary care clinicians and advanced practice providers (APPs), along with a control group, the investigators assess provider satisfaction, patient experience, and provider efficiency through qualitative and quantitative methods.

Primary Outcome

Total time on EHR (during and outside of clinic sessions) per 8 hour of patient scheduled time.

Interventions

  • OTHER Dragon Ambient eXperience (DAX) Copilot

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2023-06-19
Est. Completion 2023-12-15
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT06329427 record still lists

NCT06329427 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which Dragon Ambient eXperience (DAX) Copilot is the first listed.

NCT06329427 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06329427 about?

NCT06329427 is a clinical study titled "Dragon Ambient eXperience (DAX) Copilot Evaluation". AI solutions like, Dragon Ambient eXperience (DAX) Copilot (Nuance/Microsoft), hold the potential to significantly enhance provider and patient interactions and alleviate pain points that contribute to burn out. Atrium Health was the first healthcare system in the world to pilot Nuance's DAX Copilot...

What is the current status of trial NCT06329427?

This trial is currently completed. It is a NA study. The enrollment target is 238 participants. The study started on 2023-06-19. Estimated completion is 2023-12-15.

What interventions are being tested in trial NCT06329427?

The interventions under investigation include: Dragon Ambient eXperience (DAX) Copilot (OTHER).

Who is sponsoring clinical trial NCT06329427?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06329427's enrollment target sits among peer trials

238 459th of 2000 higher than 1,540 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT05400252 · 238 participants · NA

    Whole Health in VA Mental Health: Omnis Salutis

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

  • NCT06452797 · 238 participants · NA

    Prognostic Estimates Among ICU Clinicians

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06329427, the US trial registry maintained by the National Library of Medicine. NCT06329427 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.